172 related articles for article (PubMed ID: 36817634)
1. Axillary Lymph Node Uptake on
Otomi Y; Shinya T; Kasai H; Okada N; Matsushita T; Higashi K; Matsuzaki S; Hiroshima Y; Kubo M; Otsuka H; Harada M
Mol Imaging Radionucl Ther; 2023 Feb; 32(1):13-19. PubMed ID: 36817634
[TBL] [Abstract][Full Text] [Related]
2. [
Skawran S; Gennari AG; Dittli M; Treyer V; Muehlematter UJ; Maurer A; Burger IA; Mader C; Messerli O; Grünig H; Gebhard C; Huellner MW; Curioni-Fontecedro A; Berger C; Messerli M
Eur Radiol; 2022 Jan; 32(1):508-516. PubMed ID: 34156552
[TBL] [Abstract][Full Text] [Related]
3. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
4. The systemic impact of different COVID-19 vaccines in 2-[18F] FDG-PET/CT.
Nazerani-Zemann T; Pernthaler B; Schwantzer G; Gstettner C
Sci Rep; 2023 Dec; 13(1):21838. PubMed ID: 38071353
[TBL] [Abstract][Full Text] [Related]
5. Temporary Reactive Response of Axillary Lymph Nodes to COVID-19 Vaccination on
Notohamiprodjo S; Eiber M; Lohrmann C; Weber WA
J Nucl Med; 2022 Nov; 63(11):1673-1676. PubMed ID: 35241484
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 vaccine related hypermetabolic lymph nodes on PET/CT: Implications of inflammatory findings in cancer imaging.
Calabria F; Bagnato A; Guadagnino G; Toteda M; Lanzillotta A; Cardei S; Tavolaro R; Leporace M
Oncol Res; 2023; 31(2):117-124. PubMed ID: 37304242
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 mRNA Vaccination: Age and Immune Status and Its Association with Axillary Lymph Node PET/CT Uptake.
Eifer M; Tau N; Alhoubani Y; Kanana N; Domachevsky L; Shams J; Keret N; Gorfine M; Eshet Y
J Nucl Med; 2022 Jan; 63(1):134-139. PubMed ID: 33893188
[TBL] [Abstract][Full Text] [Related]
8. Frequency and Characteristics of Nodal and Deltoid FDG and
Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
[No Abstract] [Full Text] [Related]
9. Increased
Otomi Y; Irahara S; Inoue H; Shinya T; Otsuka H; Harada M
Mol Imaging Radionucl Ther; 2022 Jun; 31(2):169-171. PubMed ID: 35771098
[TBL] [Abstract][Full Text] [Related]
10. Duration of 18F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccination.
Thomassen A; Lerberg Nielsen A; Gerke O; Johansen A; Petersen H
Eur J Nucl Med Mol Imaging; 2011 May; 38(5):894-8. PubMed ID: 21340453
[TBL] [Abstract][Full Text] [Related]
11. Axillary lymph node accumulation on FDG-PET/CT after influenza vaccination.
Shirone N; Shinkai T; Yamane T; Uto F; Yoshimura H; Tamai H; Imai T; Inoue M; Kitano S; Kichikawa K; Hasegawa M
Ann Nucl Med; 2012 Apr; 26(3):248-52. PubMed ID: 22271546
[TBL] [Abstract][Full Text] [Related]
12. Unilateral axillary lymph node fluorodeoxyglucose uptakes after coronavirus disease 2019 vaccination.
Chikasue T; Kurata S; Sumi A; Matsuda A; Tsubaki F; Fujimoto K; Abe T
Asia Ocean J Nucl Med Biol; 2022; 10(2):142-146. PubMed ID: 35800417
[TBL] [Abstract][Full Text] [Related]
13. Frequency and intensity of [
Maurer A; Schiesser H; Skawran S; Gennari AG; Dittli M; Burger IA; Mader C; Berger C; Eberli D; Huellner MW; Messerli M
BJR Open; 2022; 4(1):20210084. PubMed ID: 36017171
[TBL] [Abstract][Full Text] [Related]
14. Hypermetabolic Axillary Lymph Nodes Associated with COVID-19 Vaccination in Breast Cancer Management.
Taşçı C; Dirican A; Sözbilen EM; Pehlivan FS; Serter S
Mol Imaging Radionucl Ther; 2023 Jun; 32(2):181-185. PubMed ID: 37337878
[TBL] [Abstract][Full Text] [Related]
15. [
Nogami M; Tsujikawa T; Maeda H; Kosaka N; Takahashi M; Kinoshita N; Mori T; Makino A; Kiyono Y; Murakami T; Goi T; Okazawa H
Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296702
[TBL] [Abstract][Full Text] [Related]
16. [
Kubota K; Saginoya T; Ishiwata K; Nakasato T; Munechika H
Ann Nucl Med; 2022 Apr; 36(4):340-350. PubMed ID: 35098436
[TBL] [Abstract][Full Text] [Related]
17. The Effects of CoronaVac (Sinovac) and BNT162b2 (BioNTech/Pfizer) Vaccination on Oncologic
Şan H; Alagöz E
Mol Imaging Radionucl Ther; 2022 Oct; 31(3):179-190. PubMed ID: 36268854
[TBL] [Abstract][Full Text] [Related]
18. Examination of iatrogenic FDG accumulation after COVID-19 vaccination.
Takahashi K; Manabe O; Shizukuishi K; Shibata H; Kawakami H; Otsuka A; Oyama-Manabe N
Ann Nucl Med; 2024 Jun; 38(6):409-417. PubMed ID: 38563890
[TBL] [Abstract][Full Text] [Related]
19. Comparison between viral vector and mRNA based COVID-19 vaccination in prevalence and severity of regional immune reactions, and
Ayati N; Evans S; Zakavi SR; Gruenewald SM
Asia Ocean J Nucl Med Biol; 2023; 11(1):4-12. PubMed ID: 36619184
[TBL] [Abstract][Full Text] [Related]
20. Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine.
Burger IA; Husmann L; Hany TF; Schmid DT; Schaefer NG
Clin Nucl Med; 2011 Oct; 36(10):848-53. PubMed ID: 21892032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
